期刊文献+

抗转铁蛋白受体双价抗体的构建、表达及鉴定 被引量:2

Construction,expression and characterization of a bivalent single chain variable fragment against transferrin receptor
下载PDF
导出
摘要 目的:抗转铁蛋白受体(TfR)双价抗体(bsFv)构建、表达及其与细胞结合的活性鉴定。方法:以抗TfR的单链抗体(scFv)为模板,设计引物引入中间连接肽(G4S)及酶切位点AscI,通过PCR方法扩增两条scFv片段,将其连接并克隆至原核表达载体pAB1,转化大肠杆菌TG1,阳性菌经IPTG诱导表达,FCM检测bsFv与K562,HepG2肿瘤细胞结合的活性及特异性。结果:酶切鉴定及DNA测序证明该bsFv构建成功;SDS-PAGE、Western blot鉴定表明表达蛋白分子量与bsFv理论值一致;FCM结果证明bsFv可与K562,HepG2肿瘤细胞特异性结合,且结合的阳性率较scFv有所提高。结论:成功构建了抗转TfR的bsFv,且能与K562,HepG2肿瘤细胞特异性结合。 Objective: To construct and express bsFv against transferrin receptor, and identify its cell conjugation activity. Methods:Designed PCR primers from the parent scFv to introduce interlinker G4 S and the restriction endonuclease AscI. Two scFv fragments were produced by PCR. The two scFv fragments gene were connected into the secretory expression vector pAB1 and transformed into E. coli. TG1. The positive clones were induced by IPTG. The protein was identified by SDS-PAGE and Western blot. Cell conjugation activity of bsFv was characterized by FCM. Results :The digesting and sequencing results of bsFv were demonstrated that the constructing was successful. Protein was analyzed by Western blot, which molecular weight was identical with the protein size of bsFv. The results of FCM proved that bsFv had the specificity of conjugating with TfR on the cell surface. The avidity of bsFv was higher than that of the parent scFv. Conclusion: BsFv against transferrin receptor have been successfully constructed and expressed. Our study demonstrated expression products could specifically bind to TfR on the cell surface of K562.
出处 《中国免疫学杂志》 CAS CSCD 北大核心 2008年第1期59-61,共3页 Chinese Journal of Immunology
基金 "863"国家高新技术发展计划(2006AA02Z158) 教育部博士点专项资金(20060487024) 湖北省十一五重大科技攻关项目(2006AA301A05)资助
关键词 转铁蛋白受体 单链抗体 双价抗体 Transferrin receptor Single chain variable fragment Bivalent scFv
  • 相关文献

参考文献7

  • 1Prost A C,Menegaux F,Langlois P et al.Differential transferrin receptor density in human colorectal cancer:a potential probe for diagnosis and therapy[J].Int J Oncol,1998;13(4):871-875.
  • 2Takubo T,Kumura T,Nakao T et al.Clinical usefulness of combined measurements of serum soluble transferrin receptor levels and serum interleukin-18 levels at determination of serum KL-6 levels in haematoingic malignancies[J].Acta Haematol,2000;104(2-3):141-143.
  • 3Gosk S,Vermehren C,Storm G et al.Targeting anti-transferrin receptor antibody(OX26)and OX26-conjugated lipesomes to brain capillary endothelial cells using In situ perfusion[J].Cerebral Blood Flow & Metabolism,2004;24(11):1193-1204.
  • 4Pirollo K F,Dngata J,Wang P et al.A tumor-targeted nanodelivery system to improve early MRI detection of cancer[J].Mol Imaging,2006;5(1):41-52.
  • 5Asai T,Trinh R,Penichet M L et al.A human biotin acceptor domain allows site-specific conjugation of an enzyme to an antibody-avidin fusion protein for targeted drug delivery[J].Biomolecular engineering,2005;21(6):145-155.
  • 6朱慧芬,杨道锋,沈关心,周春.抗转铁蛋白受体单链抗体原核表达载体的构建和表达[J].华中科技大学学报(医学版),2004,33(4):402-404. 被引量:3
  • 7叶庆,王志华,朱慧芬,王硕,沈关心.抗CD71人-鼠嵌合抗体对活化淋巴细胞的效应[J].中华微生物学和免疫学杂志,2004,24(7):509-513. 被引量:4

二级参考文献20

  • 1Kruse C A, Lamb C, Hogan S et al. Purified herpes simplex thymidine kinase retroviral particles. Ⅱ. Influence of clinical parameters and bystander killing mechanisms. Cancer Gene Ther, 2000, 7:118
  • 2Christopher C A, Nielsen M D, Donald W et al. Herpes simplex thymidine kinase gene therapy is required for complete regression of murine colon adenocarcinoma.AmSurg, 1997, 63: 617
  • 3Cook J D, Skikne B S, Baynes R D. Serum transferrin receptor. AnnuRev Med, 1993, 44:63
  • 4Boado R J, Ji A, Pardridge W M. Cloning and expression in Pichia pastoris of a genetically engineered single chain antibody against the rat transferrin receptor. J Drug Target , 2000, 8:403
  • 5Huebers HA, Finch CA. The physiology of transferring and transferring receptors. Physiol Rev, 1987, 67: 520-525.
  • 6May Ws Jr, Cuatrecassas P. Transferrin receptor: its biological significance. J Membr Biol, 1985, 88: 205-210.
  • 7Pattanapanyassat K, Hoy TG. Expression of cell surface transferring receptor and intracellular ferritin after in vitro stimulation of peripheral blood T lymphocytes. EurJ Haematol, 1991, 47: 140-145.
  • 8Weiss A. Structure and function of the T cell antigen receptor. J Clin Invest, 1990, 86: 1015-1023.
  • 9Marrack P, Kappler J. The T cell receptor. Science, 1987, 238: 1073-1082.
  • 10Woodward JE, Bayer AL, Chavin KD, et al. Anti-transferrin receptor monoclonal antibody-a novel immunosuppressant. Transplantation, 1998,65: 6-9.

共引文献5

同被引文献22

  • 1朱慧芬,杨道锋,沈关心,周春.抗转铁蛋白受体单链抗体原核表达载体的构建和表达[J].华中科技大学学报(医学版),2004,33(4):402-404. 被引量:3
  • 2Gomme P T, McCann K B, Bertolini J. Transferrin: structure, function and potential therapeutic actions [ J ]. Drug Discov Today, 2005 ; 10 (4) : 267- 273.
  • 3Prutki M, PoljakOBlazi M, Jakopovic M et al. Altered iron metabolism, transferrin receptorl and ferritin in patients with colon cancer[J]. Cancer Lett, 2006 ; 238(2) : 188-196.
  • 4Pirollo K F, Dagata J, Wang P et al. A tumor-targeted nanodelivery system to improve early MRI detection of cancer[J]. Mol Imaging, 2006 ;5( 1 ): 41-52.
  • 5Asai T,Trinh R,Penichet M L et al.A human biotin acceptor domain allows site-specific conjugation of an enzyme to an antibody-avidin fusion protein for targeted drug delivery [ J]. Biomolecular Engineering, 2005;21 (6) : 145-155.
  • 6Homey B, Muller A, Zlotnik A. Chemokines: A gents for the immunotherapy of cancer[J]. Nat Rev Immunol,2002;2(3) : 175-184.
  • 7Schimanski Carl C, Rbahre Rudige, Gockel Ines et al. Chemokine receptor CCR7 enhances intrahepatic and lymphatic dissemination of human hepatocellular cancer [ J]. Oncol Rep, 2006; 16( 1 ) : 109-113.
  • 8Yanagawa Y, Onoe K. CCL19 induces rapid dendritic extension of murine dendritic cells[J]. Blood,2002; 100(6) : 1948-1956.
  • 9Eo S K, Lee S, Kumaraguru U et al. Immunopotentiation of DNA vaccine against herpes simplex virus via co-delivery of plasmid DNA expressing CCR7 ligands[J]. Vaccine,2001 ; 19 (32) :4685-4693.
  • 10Keane M P, Belperio J A, Xue Y Yet al. Depletion of CXCR2 inhibits tumor growth and angiogenesis in a murine model of lung cancer[J]. Immunol, 2004; 172 ( 5 ) : 2853 -2860.

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部